Logo image of HCWC

HEALTHY CHOICE WELLNESS CORP (HCWC) Stock Fundamental Analysis

NYSEARCA:HCWC - NYSE Arca - US42227T1051 - Common Stock - Currency: USD

0.3721  0 (-0.83%)

Fundamental Rating

2

Overall HCWC gets a fundamental rating of 2 out of 10. We evaluated HCWC against 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of HCWC have multiple concerns. HCWC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HCWC has reported negative net income.
In the past year HCWC has reported a negative cash flow from operations.
HCWC Yearly Net Income VS EBIT VS OCF VS FCFHCWC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -13.21%, HCWC is doing worse than 82.93% of the companies in the same industry.
HCWC has a Return On Equity of -189.35%. This is amonst the worse of the industry: HCWC underperforms 95.12% of its industry peers.
Industry RankSector Rank
ROA -13.21%
ROE -189.35%
ROIC N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWC Yearly ROA, ROE, ROICHCWC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

With an excellent Gross Margin value of 39.02%, HCWC belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
HCWC's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for HCWC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
HCWC Yearly Profit, Operating, Gross MarginsHCWC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HCWC remains at a similar level compared to 1 year ago.
The debt/assets ratio for HCWC is higher compared to a year ago.
HCWC Yearly Shares OutstandingHCWC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
HCWC Yearly Total Debt VS Total AssetsHCWC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 1.81, we must say that HCWC is in the distress zone and has some risk of bankruptcy.
HCWC has a Altman-Z score of 1.81. This is in the lower half of the industry: HCWC underperforms 75.61% of its industry peers.
A Debt/Equity ratio of 3.87 is on the high side and indicates that HCWC has dependencies on debt financing.
With a Debt to Equity ratio value of 3.87, HCWC is not doing good in the industry: 92.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.87
Debt/FCF N/A
Altman-Z 1.81
ROIC/WACCN/A
WACC11.46%
HCWC Yearly LT Debt VS Equity VS FCFHCWC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.81 indicates that HCWC may have some problems paying its short term obligations.
The Current ratio of HCWC (0.81) is worse than 80.49% of its industry peers.
A Quick Ratio of 0.27 indicates that HCWC may have some problems paying its short term obligations.
With a Quick ratio value of 0.27, HCWC is not doing good in the industry: 73.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.27
HCWC Yearly Current Assets VS Current LiabilitesHCWC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

HCWC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.68%, which is quite impressive.
Looking at the last year, HCWC shows a very strong growth in Revenue. The Revenue has grown by 24.57%.
Measured over the past years, HCWC shows a very strong growth in Revenue. The Revenue has been growing by 83.46% on average per year.
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, HCWC will show a very strong growth in Earnings Per Share. The EPS will grow by 40.41% on average per year.
Based on estimates for the next years, HCWC will show a quite strong growth in Revenue. The Revenue will grow by 13.98% on average per year.
EPS Next Y40%
EPS Next 2Y40.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.88%
Revenue Next 2Y13.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HCWC Yearly Revenue VS EstimatesHCWC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
HCWC Yearly EPS VS EstimatesHCWC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

HCWC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HCWC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWC Price Earnings VS Forward Price EarningsHCWC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCWC Per share dataHCWC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as HCWC's earnings are expected to grow with 40.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.41%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCWC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHY CHOICE WELLNESS CORP

NYSEARCA:HCWC (5/21/2025, 1:11:09 PM)

0.3721

0 (-0.83%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-28 2025-03-28/bmo
Earnings (Next)N/A N/A
Inst Owners2.49%
Inst Owner Change-40.12%
Ins Owners18.11%
Ins Owner Change0%
Market Cap3.93M
Analysts82.86
Price Target2.04 (448.24%)
Short Float %1.15%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 1.65
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS6.56
BVpS0.23
TBVpS-0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.21%
ROE -189.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.02%
FCFM N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
F-Score5
Asset Turnover2.03
Health
Industry RankSector Rank
Debt/Equity 3.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.97%
Cap/Sales 0.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.27
Altman-Z 1.81
F-Score5
WACC11.46%
ROIC/WACCN/A
Cap/Depr(3y)22.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y40%
EPS Next 2Y40.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year13.88%
Revenue Next 2Y13.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.36%
OCF growth 3YN/A
OCF growth 5YN/A